Published in J Natl Cancer Inst on June 09, 2009
Pancreatic cancer. Lancet (2004) 11.63
Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway. Cancer Res (2010) 1.43
Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells. Mol Cancer Ther (2010) 1.31
Identification of Quality Measures for Performance of and Interpretation of Data From Esophageal Manometry. Clin Gastroenterol Hepatol (2015) 1.06
Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB (Oxford) (2012) 0.99
Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality. Ann Surg (2015) 0.86
Addressing the appropriateness of elective colon resection for diverticulitis: a report from the SCOAP CERTAIN collaborative. Ann Surg (2014) 0.85
Development of quality measures for the care of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2014) 0.81
Current state of surgical management of pancreatic cancer. Cancers (Basel) (2011) 0.79
Pancreatic cancer-improved care achievable. World J Gastroenterol (2014) 0.79
Quality pancreatic cancer care: it's still mostly about volume. J Natl Cancer Inst (2009) 0.79
Rankings versus reality in pancreatic cancer surgery: a real-world comparison. HPB (Oxford) (2013) 0.78
Opportunities of improvement in the management of pancreatic and periampullary tumors. Scand J Gastroenterol (2013) 0.78
Rethinking elective colectomy for diverticulitis: a strategic approach to population health. World J Gastroenterol (2014) 0.77
Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach. Ann Surg Oncol (2016) 0.75
Perception Is Reality: quality metrics in pancreas surgery - a Central Pancreas Consortium (CPC) analysis of 1399 patients. HPB (Oxford) (2016) 0.75
Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas. Mod Pathol (2016) 0.75
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure. P T (2014) 0.75
Quality Indicators in Pancreatic Surgery: Lessons Learned from the German DGAV StuDoQ|Pancreas Registry. Visc Med (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45
The quality of health care delivered to adults in the United States. N Engl J Med (2003) 50.33
Hospital volume and surgical mortality in the United States. N Engl J Med (2002) 25.79
The quality of care. How can it be assessed? JAMA (1988) 24.47
Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med (2002) 11.14
Impact of hospital volume on operative mortality for major cancer surgery. JAMA (1998) 11.05
Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann Intern Med (2008) 8.01
Relationship between Medicare's hospital compare performance measures and mortality rates. JAMA (2006) 7.20
The unintended consequences of publicly reporting quality information. JAMA (2005) 6.55
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA (2008) 6.29
Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg (1995) 5.90
Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med (2005) 5.29
The unintended consequences of measuring quality on the quality of medical care. N Engl J Med (1999) 4.05
Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA (2004) 4.05
The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol (2008) 3.82
National failure to operate on early stage pancreatic cancer. Ann Surg (2007) 3.65
Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA (1998) 3.19
Public reporting of surgical mortality: a survey of New York State cardiothoracic surgeons. Ann Thorac Surg (1999) 3.00
Hospital volume and late survival after cancer surgery. Ann Surg (2007) 2.93
Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg (2002) 2.89
Measuring the quality of surgical care: structure, process, or outcomes? J Am Coll Surg (2004) 2.86
Defining and measuring quality of care: a perspective from US researchers. Int J Qual Health Care (2000) 2.73
Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care (2003) 2.69
Achieving and sustaining improved quality: lessons from New York State and cardiac surgery. Health Aff (Millwood) (2002) 2.46
Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol (2003) 2.44
Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg (2005) 2.38
Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg (1998) 2.32
The appropriateness method. Med Decis Making (2004) 2.17
The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol (2004) 1.94
Evaluation of the agency for healthcare research and quality pediatric quality indicators. Pediatrics (2008) 1.91
Eulogy for a quality measure. N Engl J Med (2007) 1.86
Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock. Am Heart J (2007) 1.78
Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Cancer (2007) 1.63
Volume and process of care in high-risk cancer surgery. Cancer (2006) 1.52
Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg (2008) 1.46
Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst (2006) 1.34
Sensitivity and specificity of the RAND/UCLA Appropriateness Method to identify the overuse and underuse of coronary revascularization and hysterectomy. J Clin Epidemiol (2001) 1.27
Developing quality indicators for elderly patients undergoing abdominal operations. J Am Coll Surg (2005) 1.11
Outcomes in oncologic surgery: does volume make a difference? World J Surg (2005) 1.06
Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg (2008) 1.05
Hospital-to-hospital variation in lymph node detection after colorectal resection. Cancer (2004) 0.95
Reliability of clinical guideline development using mail-only versus in-person expert panels. Med Care (2003) 0.94
Are appropriateness criteria ready for use in clinical practice? N Engl J Med (2001) 0.87
The California Cardiac Surgery and Intervention Project: evolution of a public reporting program. Am Surg (2006) 0.84
Quality in surgery: current issues for the future. World J Surg (2005) 0.82
Quality indicators in bariatric surgery: improving quality of care. Surg Obes Relat Dis (2006) 0.79
Hospital Characteristics and the Agency for Healthcare Research and Quality Inpatient Quality Indicators: A Systematic Review. J Healthc Qual (2016) 0.78
Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst (2004) 10.61
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg (2006) 7.18
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg (2004) 5.12
Extent of surgery affects survival for papillary thyroid cancer. Ann Surg (2007) 4.73
Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol (2009) 4.53
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87
The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol (2008) 3.82
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
National failure to operate on early stage pancreatic cancer. Ann Surg (2007) 3.65
Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg (2009) 3.55
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery (2007) 3.42
Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg (2007) 3.38
Disparities in the utilization of high-volume hospitals for complex surgery. JAMA (2006) 3.35
Updated population-based review of carcinoid tumors. Ann Surg (2004) 3.21
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg (2009) 3.07
Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. Ann Surg (2009) 3.05
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 3.03
Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique? Ann Surg (2011) 2.87
Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer (2007) 2.85
Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg (2008) 2.80
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg (2015) 2.79
Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol (2008) 2.74
A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg (2012) 2.72
The aging population and its impact on the surgery workforce. Ann Surg (2003) 2.70
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med (2012) 2.62
Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients. Ann Surg (2005) 2.58
Effect of delay to operation on outcomes in adults with acute appendicitis. Arch Surg (2010) 2.53
Blueprint for a new American College of Surgeons: National Surgical Quality Improvement Program. J Am Coll Surg (2008) 2.53
Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst (2008) 2.46
A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum (2005) 2.45
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol (2002) 2.44
Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg (2013) 2.37
Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg (2004) 2.35
Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol (2009) 2.35
Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. JAMA (2013) 2.31
Rates of colon and rectal cancers are increasing in young adults. Am Surg (2003) 2.30
Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg (2004) 2.29
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg (2013) 2.26
Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal. Ann Surg Oncol (2008) 2.20
Do young colon cancer patients have worse outcomes? World J Surg (2004) 2.20
Validity and feasibility of the american college of surgeons colectomy composite outcome quality measure. Ann Surg (2013) 2.18
Surgical privileging and credentialing: a report of a discussion and study group of the American Surgical Association. J Am Coll Surg (2009) 2.18
Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am (2006) 2.15
Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg (2014) 2.15
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol (2008) 2.15
Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. Adv Surg (2010) 2.14
The influence of resident involvement on surgical outcomes. J Am Coll Surg (2011) 2.12
Risk adjustment for comparing hospital quality with surgery: how many variables are needed? J Am Coll Surg (2010) 2.12
Hospitalization before and after gastric bypass surgery. JAMA (2005) 2.12
Use and outcomes of laparoscopic-assisted colectomy for cancer in the United States. Arch Surg (2008) 2.10
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg (2007) 2.10
Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer (2008) 2.09
Major bile duct injuries associated with laparoscopic cholecystectomy: effect of surgical repair on quality of life. Ann Surg (2002) 2.09
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement. Ann Surg Oncol (2012) 2.08
Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery (2006) 2.07
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res (2002) 2.07
Surgical considerations for the management and resection of esophageal gastrointestinal stromal tumors. Ann Thorac Surg (2007) 2.04
Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw (2011) 2.03
Malignancies of the appendix: beyond case series reports. Dis Colon Rectum (2005) 2.02
Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol (2004) 2.01
Adherence with postdischarge venous thromboembolism chemoprophylaxis recommendations after colorectal cancer surgery among elderly Medicare beneficiaries. Ann Surg (2014) 1.97
Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg (2012) 1.94
Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol (2009) 1.90
Reliability of superficial surgical site infections as a hospital quality measure. J Am Coll Surg (2011) 1.90
Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg (2008) 1.90
A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg (2006) 1.89
Association between occurrence of a postoperative complication and readmission: implications for quality improvement and cost savings. Ann Surg (2013) 1.87
Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg (2012) 1.86
Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms: a statewide experience. J Vasc Surg (2006) 1.84
Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. J Am Coll Surg (2013) 1.84
Identification of specific quality improvement opportunities for the elderly undergoing gastrointestinal surgery. Arch Surg (2009) 1.83
A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg (2010) 1.83
Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. J Gastrointest Surg (2007) 1.83
Development of an American College of Surgeons National Surgery Quality Improvement Program: morbidity and mortality risk calculator for colorectal surgery. J Am Coll Surg (2009) 1.83
Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol (2010) 1.82
Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol (2004) 1.80